Kathryn R. Strong
Biography
Kathryn R. Strong advises clients on domestic and cross-border mergers and acquisitions, joint ventures and other strategic transactions. She has extensive experience as lead M&A counsel for Fortune 100 clients and financial sponsors on buy-side and sell-side transactions, having advised on transactions ranging in size from USD 10 million to USD 20 billion. In addition to her experience closing transactions with US buyers, sellers and targets, she has counseled clients on numerous complex multijurisdictional carve-out transactions in regulated industries, as well as other internal corporate restructurings and tax-efficient transactions. Kathryn has been recognized as a “Rising Star” in M&A by Thomson Reuters since 2022.
Kathryn is highly experienced in partnering with her clients on major projects to achieve strategic objectives and meet critical deal timelines, and brings an emphasis on commerciality, efficiency and responsiveness to her deals. Kathryn also counsels clients on corporate governance and other general corporate matters.
Representative Legal Matters
- Advised Physicians Realty Trust (NYSE: DOC) on numerous transactions, including its USD 750 million acquisition of a portfolio of medical office facilities from Landmark Healthcare Facilities, and its USD 21 billion merger with Healthpeak Properties.
- Advised Autajon Group on numerous acquisitions, including UK-based Royston Labels and Simply Cartons, and U.S.-based Zapp Packaging.
- Advised Booking Holdings (NASDAQ: BKNG) on various matters including the acquisition of software start-up FareHarbor, Inc.
- Advised Robert Half (NYSE: RHI) and its affiliate, Protiviti Inc., on numerous acquisitions of internal audit, data analytics, technology and risk consulting service businesses in the U.S.
- Advised Safran on its pending acquisition of Collins Aerospace’s high-technology actuation and flight control activities in a transaction valued at USD 1.8 billion.
- Advised Galapagos NV on its 10-year global research and development collaboration with Gilead Sciences, Inc.
- Advised Abbott Laboratories (NYSE: ABT) on a wide range of transactions, including sale of the St. Jude Medical Angio-Seal and FemoSeal vascular closure devices business to Terumo Corporation, and sale of a portfolio of branded specialty and generic drugs in developed markets outside the United States to Mylan NV.
- Advised AbbVie (NYSE: ABBV) on transactions including dispositions of commercialized and clinical-stage products.
- Advised Walgreens in its specialty pharmacy and mail service pharmacy joint venture with Prime Therapeutics, a transaction valued at US 2 billion.
- Advised ICU Medical, Inc. on the acquisition of Excelsior Medical Corporation from RoundTable Healthcare Partners, along with the simultaneous sale by ICU of Excelsior’s pre-filled saline and flush syringe business to Medline Industries, Inc.
- Advised McDonald's on its acquisition of artificial intelligence speech start-up Apprente, Inc.
- Advised portfolio companies and sponsors on various lower and middle-market acquisitions.
Professional Associations and Memberships
- Chicago Bar Association - Member
- Chicago Council on Global Affairs, Corporate Young Professional
Admissions
- Illinois~United States
Education
- Northwestern University Pritzker School of Law (J.D., Associate Editor, Northwestern University Law Review)
- Northwestern University (B.A., cum laude)